(Q36958331)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Current state of biologicals in the management of systemic vasculitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Peter Lamprecht

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Jörg Steinmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Peer M Aries

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Wolfgang L Gross

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

Annals of the New York Academy of Sciences

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

1110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

261-270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

cites work

Small-vessel vasculitis

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Pathogenesis of Wegener's granulomatosis: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Complex genetics of Wegener granulomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Staphylococcus aureus and Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Etanercept plus standard therapy for Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Advances in the therapy of Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Mechanisms of infliximab: the reverse side of a drug effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Proteinase 3 is an IL-32 binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener's granulomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

Differential p38 mitogen-activated protein kinase target phosphorylation in responders and nonresponders to infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.028

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1423.028

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911441%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference